1.646.889.1200|info@lifescipublicrelations.com

Oxurion’s CEO Dr. Patrik De Haes discusses three pipeline candidates for diabetic eye disease

/, video/Oxurion’s CEO Dr. Patrik De Haes discusses three pipeline candidates for diabetic eye disease

Oxurion’s CEO Dr. Patrik De Haes discusses three pipeline candidates for diabetic eye disease

Patrik De Haes, MD, CEO of Oxurion, discusses the company’s three disease-modifying drug candidates for the treatment of diabetic eye disease with EyeWire News at the Ophthalmology Innovation Summit in Chicago.

By | 2018-11-20T09:59:09-04:00 November 19th, 2018|News, video|Comments Off on Oxurion’s CEO Dr. Patrik De Haes discusses three pipeline candidates for diabetic eye disease

About the Author:

Related Posts

LifeSci Public Relations

LifeSci Public Relations LLC is a corporate communications and public relations firm helping clients engage their corporate audiences and achieve their business objectives via a broad array of traditional, social and digital media tools.